Peak Surgical out of Palo Alto, California has received FDA approval for its tonsil and adenoid tissue dissection device. The PEAK PlasmaBlade TnA, which features interchangeable tips, is based on the recently introduced PlasmaBlade system that aims to replace the Bovie as a standard dissection and coagulation device. The primary advantage of PEAK’s technology is the low thermal footprint of the cutting tip, leading to less damage to the tissue around the dissection site.
All of the PlasmaBlade tissue dissection surgical devices are used in conjunction with PEAK Surgical’s PULSAR Generator, which supplies pulsed waveforms that produce short plasma-mediated electrical discharges through the PlasmaBlade. Because the radiofrequency is provided in short on-and-off pulses with low duty cycle, and the blade is insulated, heat diffusion and associated heat damage to surrounding tissues is limited, resulting in less collateral damage and more precise tissue dissection. In contrast, most radiofrequency-based surgical devices use continuous voltage waveforms and un-insulated electrodes to cut tissue.
The PlasmaBlade provides surgeons with a single device that offers:
* the precision of a traditional scalpel;
* the bleeding control of traditional electrosurgery technology;
* minimized thermal damage;
* the ability to quickly and easily cut through all types of soft tissue, including skin, fat and muscle;
* the ability to operate in a wet or dry surgical field.
Product page: PlasmaBlade Family…
Press release: PEAK Surgical Introduces PEAK PlasmaBlade™TnA…
Flashbacks: PlasmaBlade Finds New Uses With New Attachments; PlasmaBlade System Gets FDA Go Ahead; Peak PlasmaBlade Wants to Be The New Bovie